Press Releases keyboard_arrow_down
Media Coverage keyboard_arrow_down
Events keyboard_arrow_down
Blog keyboard_arrow_down
Webinars keyboard_arrow_down
Brochures keyboard_arrow_down

Media Relations

Vancive Media Contact

Bob Giuliano                                   T: +1 610-328-1051               

Vancive Marketing Communications Contact

Suzanne Kelly, T: + 1 312-629-4607

CareFusion Media Contact

Troy Kirkpatrick, T: +1 858-617-2361

CareFusion Investor Contact

Jim Mazzola, T: +1 858-617-1203







Vancive Medical Technologies, CareFusion Sign Agreement for Antimicrobial Dressing

CHICAGO – November 19, 2013 – Vancive Medical Technologies™ and CareFusion Corporation (NYSE: CFN) today announced an exclusive agreement in the United States, Canada and Mexico for the licensing and distribution of Vancive’s BeneHold™ Chlorhexidine Gluconate (CHG) antimicrobial Adhesive Technology for applications in vascular access.

Under the agreement, CareFusion will market Vancive’s unique antimicrobial adhesive technology used with transparent dressings that are ideally suited for protection of catheter insertion sites. The first product received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in September 2012 and will be co-branded under CareFusion’s new ChloraShield™ brand.

“We are excited about this collaboration, and believe it is an excellent opportunity to combine the unique capabilities of each company,” said Howard Kelly, president and general manager of Vancive Medical Technologies. “By bringing together the considerable infection prevention expertise at CareFusion and Vancive’s cutting-edge technologies, we will provide innovative solutions to the vascular access market.”

CareFusion and Vancive are working together to develop a comprehensive line of dressing products that incorporate the BeneHold™ CHG antimicrobial Adhesive Technology to meet the specific needs associated with many types of vascular access procedures. CareFusion expects to commercialize these offerings during the company’s fiscal third quarter, which begins in April.

“The collaboration with Vancive Medical Technologies and the new ChloraShieldTM line of dressings are a perfect fit with our leadership in CHG products,” said Jim Leitl, senior vice president and general manager of Medical Specialties at CareFusion. “These innovative vascular access dressings extend our clinically differentiated infection prevention and vascular access product portfolios, allowing us to create greater value for our customers.”

BeneHold is a trademark of Avery Dennison Corporation. ChloraShield is a trademark of CareFusion Corporaiton.ood pressure monitors, baby monitors, and fitness trackers. These products can help people monitor the




About Vancive Medical Technologies

Vancive Medical Technologies makes inspired advances that lead to intelligent results. The business uses the most advanced adhesive and material technologies to create products that make healthcare easier for everyone. Vancive Medical Technologies is an Avery Dennison business headquartered in Chicago, Illinois. For more information, visit

MENTOR, Ohio – March 10, 2010 – Original equipment manufacturers of medical devices can now source single-coated adhesive tapes produced in a cleanroom environment by Avery Dennison Medical Solutions. Cleanroom production helps Avery Dennison Medical Solutions meet customers' needs for adhesives that are free of foreign particles, such as dust, that could undermine product integrity.

Avery Dennison Medical Solutions produces all of its single-coated products, including urethane, nonwoven and diagnostic adhesive tapes, in the new controlled-environment facility, which is based on FDA and ISO standards. All Avery Dennison Medical Solutions adhesive tapes are produced according to customers' specifications, and the cleanroom helps meet requirements for high-precision applications ranging from prototyping to large volume production.

According to Richard Baron, senior medical product development manager, the precision cleanroom facility satisfies marketplace preferences for goods that have been produced in a cleanroom environment.  “OEMs of medical products prefer doing business with suppliers whose operations are as clean as or cleaner than their own,” Baron says, explaining the rationale behind the new facilities and equipment.

The cleanroom facility includes a new precision coater that, according to Baron, gives Avery Dennison Medical Solutions a capabilities advantage over most other suppliers of single-sided medical adhesives.  "In addition to ensuring cleaner adhesive product, our new coater has the unique ability to maintain controlled tolerances with a uniform adhesive profile during the production process,” he says.

Avery Dennison Medical Solutions offers free adhesive tape project evaluation and product specification services to OEMs and converters.





About Avery Dennison

Avery Dennison (NYSE:AVY) helps make brands more inspiring and the world more intelligent. For more than 75 years the company has been a global leader in pressure-sensitive technology and materials, retail branding and information solutions, and organization and identification products for offices and consumers. A FORTUNE 500 company with sales of $6.5 billion in 2010, Avery Dennison is based in Pasadena, California and has employees in over 60 countries. For more information, visit


About CareFusion

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife® and LTV® series ventilation and respiratory products, ChloraPrep® products, MedMined®services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs approximately 15,000 people across its global operations. More information may be found at




© 2016 Avery Dennison Corporation, All Rights Reserved.

Various trademarks and trade names are used herein and are the property of their respective owners.